Get the Stockscreener App
0.6076
2.97%
-0.0186
After Hours:
.61
0.0024
+0.39%
Bone Biologics Corp stock is traded at $0.6076, with a volume of 43,280.
It is down -2.97% in the last 24 hours and down -43.21% over the past month.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
See More
Previous Close:
$0.6262
Open:
$0.622
24h Volume:
43,280
Relative Volume:
0.14
Market Cap:
$1.10M
Revenue:
-
Net Income/Loss:
$-2.86M
P/E Ratio:
-0.2424
EPS:
-2.5071
Net Cash Flow:
$-2.57M
1W Performance:
-7.94%
1M Performance:
-43.21%
6M Performance:
-46.70%
1Y Performance:
-72.38%
1-Day Range:
$0.5843
$0.622
1-Week Range:
$0.5843
$0.6572
52-Week Range:
$0.5843
$4.1299
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.6076 | 1.10M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp Stock (BBLG) Latest News
Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn
Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn
Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Systematic Flow - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Volatility Breakout Picks - vinanet.vn
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Bone Biologics Warrants (BBLGW) Hold at $3.50 as Traders Eye Tight RangeEquity Put Call - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Bone Biologics Extends rhNELL-1 Validated Shelf Life to 32 Months as NB1 Study Advances - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Bone Biologics Corporation Achieves 32-Month Validated Shelf Life For rhNELL-1 - marketscreener.com
Bone Biologics Corp expected to post a loss of 39 cents a shareEarnings Preview - TradingView
BBLG Q1 2026 Earnings: Narrower-Than-Expected Loss of -$0.43, Though Shares Slip 5.67%Performance Review - vinanet.vn
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m - Investors in Healthcare
Bone Biologics Warrants (BBLGW) Steady at $8.0 as Tight Trading Range Takes ShapeValue ETF - dars.gov.et
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone - Orthopedics This Week
Isto Biologics Acquires NovaBone | Press Release - ACCESS Newswire
Bone Biologics Warrants (BBLGW) Hold Flat at $8.00 as Range-Bound Trading PersistsMA Cross Alert - dars.gov.et
Bone Biologics (BBLG) Dips 3.23% to $0.85 — Shares Approach Key Support at $0.81Money Flow - vinanet.vn
Bone Biologics Corp Warrants (BBLGW) Hold Steady at $8.0 Amid Low Volume ConsolidationSell Signal Alerts - vinanet.vn
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp Warrants (BBLGW) Holds Steady at $8.0 as Consolidation Pattern EmergesMESA MA - po-news-eg.net
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp SEC Filing (Jul 27, 2026) - Stock Titan
Bone Biologics Corp (BBLG) Cash Flow - TradingKey
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBLG|Bone Biologics Corp|Price:1.070|Chg%:-0.010 - TradingKey
BBLG|Bone Biologics Corp|Price:1.010|Chg%:-0.060 - TradingKey
Bone Biologics Corp (BBLG) Nears Support as Selling Pressure PersistsRetail Driven Moves - dars.gov.et
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLGW - tradingview.com
TradingKey - TradingKey
BBLG Q1 2026 Earnings: Narrowed Loss Beats Estimates, But Stock DeclinesProfit Cycle Analysis - Vinanet
Bone Biologics Corp Revenue Breakdown – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics raises $3.0M in July financing, extends rhNELL-1 shelf life to 29 months - TradingView
Bone Biologics (Nasdaq: BBLG) raises $3M, extends runway to 2027 - Stock Titan
Bone Biologics extends rhNELL-1 shelf life to 29 months - Stock Titan
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - The Manila Times
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline - dars.gov.et
Price to book forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLG - TradingView
Bone Biologics Corp (BBLG) Q1 2026 Earnings: Narrower-than-expected loss fails to lift stockPre-Announcement Alert - vinanet.vn
Form S-3 Bone Biologics Corp For: 17 July - Investing.com India
Form S-3 Bone Biologics Corp For: 17 July By Investing.com - Investing.com Nigeria
Bone Biologics (NASDAQ: BBLG) registers 6.46M warrant shares for resale - Stock Titan
Bone Biologics Corporation Files Form 8-K with SEC: Company Details, Stock Info, and Contact Information (July 2026) - Minichart
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
3.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):